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Summary: We present a case in which a stent-graft was
used to treat an aneurysm of the vertebrobasilar junction.
According to our literature search, this is one of the first
cases involving the intracranial placement of a stent-graft
and the first case in which an aneurysm of the vertebro-
basilar junction was treated in this manner. A stent-graft
can be useful device for the neuroendovascular treatment
of aneurysms in select patients.
Covered stents has not yet found widespread use in
interventional neuroradiology. Our successful treat-
ment of an intracranial aneurysm by means of a stent-
graft shows the potential of using this device.
Technique
A 35-year-old man experienced a sudden severe headache.
CT demonstrated subarachnoid hemorrhage of Hunt and Hess
grade I–II, without motor or sensory deficits. Quantitative
digital subtractive angiography (DSA) showed a wide-necked,
irregularly shaped aneurysm at the vertebrobasilar junction
(Fig 1). Its dimensions were as follows: dome size, 6 mm; neck
width, 4 mm; left vertebral artery (VA) diameter, 4 mm; basilar
artery (BA) origin diameter, 3.8 mm; right VA diameter, 1.6
mm; and body-to-neck ratio, 1.5 mm.
The aneurysm was in an area that was difficult to access.
Therefore, endovascular treatment was considered the therapy
of choice. An analysis of the geometry of the aneurysm (irreg-
ular form, wide neck) suggested a high risk with coil emboli-
zation (1, 2). Balloon test occlusion (BTO) of the left VA was
performed distal to the posterior inferior cerebellar artery
(PICA). BTO lasted 25 minutes and was well tolerated. Taking
into consideration the results of BTO and the favorable ana-
tomic conditions for stent-graft placement, we considered the
endovascular approach the method of choice.
According to the protocol for stent placement, 250 mg of
tyclodipin twice a day and 325 mg of aspirin once a day were
prescribed 72 hours before the intervention. After stent place-
ment, the patient received 250 mg of tyclodipin twice a day and
325 mg of aspirin once a day for 3 months, in addition to
low-weight heparin of a standard dose (0.3 mL Fraxiparine
twice a day) for 5 days. The procedure was performed under
local anesthesia and intravenous sedation. A 8F introducer was
positioned in right femoral artery by using a Seldinger tech-
nique. The patient received a bolus of heparin (5000 IU intra-
venously), and intermittent doses of heparin were given
throughout the procedure. A 7F, 90-cm guiding catheter (Vista
Brite Tip Multipurpose; Cordis Europa N.V., Roden, the Neth-
erlands) was positioned in the distal left VA. An 0.014-in
microguidewire (ATW; Cordis) was passed into the left poste-
rior cerebral artery as distally as possible to provide support. A
12  4-mm stent-graft (Jostent Coronary Stent Graft Supreme
System with JET coating; Jomed. Unterschleibheim, Germany)
was passed over the microguidewire and carefully positioned at
the level of the aneurysm, distal to the origin of the left PICA
and proximal to the origins of both anterior inferior cerebellar
arteries. The stent-graft was then deployed across the neck of
the aneurysm and the vertebrobasilar junction (Fig 2A). This
system consisted of a premounted stent made of ultrathin (75
m) polytetrafluoroethylene (PTFE) graft material layered be-
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FIG 1. Initial DSA with left VA injection shows the wide-necked,
irregularly shaped aneurysm of the vertebrobasilar junction (ar-
rows)
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tween two stents with reduced wall thickness. The balloon was
inflated to 11 atm. DSA with left VA injection showed total
closure of the aneurysm and good patency of the VA, BA, and
intracranial vessels (Fig 2B). The balloon and microguidewire
were removed. DSA with right VA injection showed termina-
tion of the right VA with the PICA (Fig 2C).
No technical complications or neurologic sequelae were
observed. Follow-up angiography performed 6 months after
stent placement showed no filling of the aneurysm and normal
patency of the VA and BA, with no evidence of intimal hyper-
plasia or concomitant vessel stenosis (Fig 3).
Discussion
Stents have been used in the treatment of aneu-
rysms in the last decade. There are several modalities
of stent use in such treatment. Use of a stent alone to
reduce blood flow in the sack and to create a matrix
for endothelial growth is not efficient because of the
high porosity and the need for systemic anticoagula-
tion to reduce the risk of thromboembolic complica-
tions and subacute stent thrombosis (3, 4). Stent
placement can be successful in conjunction with coil
embolization (stent-supported coil embolization) (4,
5). In this situation, the stent acts as a rigid endolu-
minal scaffold to prevent coil herniation into the
parent vessel and possibly provide an endoluminal
matrix for endothelial growth. This method has
shown good results, but some limitations may be en-
countered. For example, a microcatheter is often nav-
igated through the stent interstices only with great
difficulty (5). Also, complete obliteration of an irreg-
ularly shaped, wide-neck aneurysms is difficult, even
with the combined stent placement-coiling approach.
Finally, stents are known to induce intimal hyperpla-
sia, which can result in hemodynamically significant
stenosis (6).
In recent years, the use of covered stents has be-
came a promising alternative to other endovascular
techniques in select clinical situations. Covered stents
have been used to occlude parent vessels (7) and to
treat carotid-cavernous fistulas (8), carotid blowout
syndrome (9), and fusiform dissecting aneurysm of
the VA (10) while saving vessel patency. These re-
ports suggest that the use of stent-grafts may be the
easiest, fastest, and most efficient way to preserve a
parent artery.
PTFE-covered stents are effective in a variety of
clinical situations, with an acceptably low incident of
complications, including acute and subacute stent
thrombosis (on the condition of an optimal stent
opening) (11). Furthermore, the PTFE layer might
reduce the rate of neointimal hyperplasia and stent-
related stenosis by inhibiting the migration of inflam-
matory cells and by attenuating the diffusion of cyto-
kines (8, 12).
The main technical limitation associated with the
placement of stent-grafts in intracranial vessels is
their limited longitudinal flexibility. Another limita-
tion is related to the occlusion of side branches by the
PTFE layer and the following cerebral ischemia.
A stent-graft can be a useful device for neuroen-
FIG 2. Coronary stent-graft placement to treat an aneurysm of the vertebrobasilar junction.
A, Contrast material injection from the guiding catheter. The stent-graft (white arrowheads) is situated at the level of the aneurysm
(white arrow), distal to the origin of the left PICA (black arrow) and proximal to the origins of both anterior inferior cerebellar arteries (black
arrowheads).
B, DSA with left VA injection from the guiding catheter shows total closure of the aneurysm and good patency of the VA, BA, left PICA
(arrow), and origins of both anterior inferior cerebellar arteries (arrowheads).
C, DSA with right VA injection shows termination of right VA with the PICA (arrowheads).
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dovascular treatment in some clinical situations (eg,
small curvature of the cerebral vasculature, absence
of side branches on the stented segment or the pos-
sibility to sacrifice them). Future technical develop-
ments will likely improve stent-graft design and offer
more sophisticated delivery systems. The long-term
follow-up results of stent-graft placement, especially
in cerebral vessels, are still unknown and should be
studied in clinical trials.
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FIG 3. Follow-up angiogram obtained 6 months after stent
placement shows an absence of filling of the aneurysm, normal
patency of the VA and BA, and no evidence of intimal hyperpla-
sia or concomitant vessel stenosis.
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